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The marriage of proteomics with cell biology has produced extensive inventories of 
the proteins that inhabit several subcellular organelles.  Recent proteomic analysis 
has identified a large number of new putative transmembrane proteins in the nuclear 
envelope, and transcriptome profiling suggests that the nuclear membrane proteome 
exhibits some significant variations among different tissues.  Cell type-specific 
differences in the composition of protein subcomplexes of the nuclear envelope, 
particularly those containing the disease-associated protein lamin A, could yield 
distinctive functions and so explain the tissue-specificity of a diverse group of nuclear 
envelope-linked disorders in humans.  Considered together, these recent results 
suggest an unexpected functional complexity at the nuclear envelope.  
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An introduction to the nuclear envelope 
The past few years have seen an explosion in the number of identified nuclear 
envelope (NE) proteins as well as in the number of their associated diseases.  The 
NE (Figure 1), which is continuous with the more peripheral ER, contains an outer 
(ONM) and inner nuclear membrane (INM) that are joined at the nuclear pore 
membrane, giving rise to three different subdomains within nuclear membranes.  The 
ONM is functionally similar to the more peripheral ER, but also is thought to contain 
some distinct resident proteins.  The INM contains a large group of distinctive 
transmembrane proteins and is lined by a polymer of intermediate filament proteins 
called lamins.  As many as four major lamin subtypes (lamin A, C, B1, and B2) are 
expressed in mammalian cells in a developmentally-regulated manner.  Most lamin 
subtypes can be modified with lipid moieties that facilitate their targeting to the NE, 
and a fraction of some lamins occurs in the nucleoplasm as well as at the INM 
(reviewed in [1]).  The lamin polymer and interacting proteins at the INM collectively 
comprise the nuclear lamina.  The nuclear pore membrane is closely associated with 
nuclear pore complexes (NPCs), the main macromolecular transport channels 
across the NE.  The transport functions and proteome of the NPC have been 
extensively characterized [2,3], and will not be further considered here.  It is 
generally agreed that the lamina has a role in nuclear morphology and stability [4-6], 
and support for a wide and ever-increasing array of additional functions has emerged 
from recent studies.  Lamins and lamina-associated membrane proteins have been 
linked to activities as diverse as transcription [7-10], DNA replication [11,12], nuclear 
anchoring/ migration within the cell [13], and signaling cascades [14].  To what extent 
these are direct or indirect effects of lamina proteins remains to be elucidated. 
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Consistent with the notion that the nuclear lamina is involved in a diverse 
range of basic cellular functions, at least fifteen inherited diseases and syndromes 
have been linked to lamins A/C and certain associated NE transmembrane proteins.  
These include muscular dystrophies, lipodystrophies, neuropathy, cardiomyopathies, 
dermopathy, bone disorders, and premature aging diseases (reviewed in [15,16], 
[17,18]).  Each of these diseases affects only a limited number of tissues, yet the NE 
proteins that have been linked to disease − most notably lamins A/C, emerin, LBR, 
and MAN1 − are expressed widely in differentiated somatic cells.  Moreover, different 
mutations in the same protein can affect different tissues.  For example certain 
mutations in lamins A/C primarily affect striated muscle, while another affects 
neurons, and others target skin or fat tissue. 
It is becoming evident that many NE transmembrane proteins can engage in 
multiple distinct protein interactions [19].  Moreover, the expression level of these 
transmembrane proteins can vary between different cell types, as discussed below.  
This raises the possibility that the tissue-specificity of diseases caused by mutations 
in widely expressed lamina proteins may be a consequence of the tissue-specific 
expression patterns of their binding partners.  An analogous scenario is found in C. 
elegans, where the NE transmembrane protein UNC83 targets to the NE by an 
interaction with UNC84 [20].  At early stages of development UNC83 is only 
observed in tissues where nuclear migration occurs, whereas UNC84 is ubiquitously 
expressed.  Mutations in either of the interacting proteins result in the failure of 
nuclear migration and the same “uncoordinated” phenotype reflected as loss of worm 
mobility.   
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Roads to the nuclear envelope proteome 
The pre-proteomics catalogue of mammalian NE proteins was the product of over a 
quarter century’s work utilizing many different approaches.  Roughly three decades 
ago, lamins became the first NE proteins characterized — in large part because they 
are the most abundant proteins in isolated NEs [21,22].  Subsequently a number of 
NE transmembrane proteins (Table 1) have come to light, and human diseases have 
been linked to some of them.  LBR (Lamin B Receptor) was identified over a decade 
after lamins by its binding to lamin B1 [23].  LBR was later found to bind 
heterochromatin protein 1 (HP1) and DNA as well (reviewed in [24]).  LBR is 
homologous to yeast sterol C-14 reductase and also is enzymatically active.  
Mutations in LBR cause Pelger-Huet Anomaly [6] and Greenburg skeletal dysplasia 
[25].  The lamina-associated polypeptides, LAP1C and LAP2ß, were identified using 
monoclonal antibodies generated against proteins of a NE fraction [26,27].  LAP2ß 
has been functionally implicated, either directly or through its binding partners, in 
nuclear growth [28] and transcriptional repression [10].  LAP1 remains poorly 
characterized, but was recently shown to interact with torsinA — the protein mutated 
in early-onset torsion dystonia [29].  Nurim (nuclear rim protein) was identified by the 
screening of a GFP-cDNA fusion library for constructs that targeted to the NE [30].  
Emerin was identified genetically as the gene responsible for Emery Dreifuss 
Muscular Dystrophy [31] two years before its localization to the NE was established 
by antibody labeling of cells [32].  MAN1 was identified from an autoimmune serum 
that gave nuclear “rim” staining characteristic of lamins [33].  It has been linked to 
three related bone disorders: osteopoikilosis, Buschke-Ollendorff syndrome and 
melorheostosis [18].  Though MAN1- and emerin-linked diseases in humans affect 
distinct tissues, in C. elegans they are synthetically lethal in embryos, suggesting a 
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common pathway in their functions [34].  The first mammalian member of a new 
group or proteins, termed Synes (and subsequently also called Nesprins [35]) was 
identified in a 2-hybrid screen for partners of a kinase of the postsynaptic membrane 
in muscle: Syne-1 was found to target to the NE using polyclonal antibodies [36].  
This family is characterized by variable numbers of spectrin repeats and a conserved 
domain referred to as a KASH domain (for Klarsicht; [37], Anc-1, Syne-1 homology).  
Some of the isoforms, which also contain an actin-binding domain, are the largest 
proteins at the NE and are important for nuclear positioning (reviewed in [38]).  
UNCL was uncovered in a study to determine why nicotinic acetylcholine receptors 
do not properly assemble in many mammalian cell lines, and was found to target to 
the NE by overexpression of a tagged fusion protein [39].  Some of these proteins 
are thought to be concentrated in the INM and others may be located in the ONM, 
although decisive immunolocalization to either membrane has not yet been shown 
for many of them [38].  Two NE transmembrane proteins, gp210 and POM121, were 
identified as components of the NPC [40,41].  These are the only transmembrane 
proteins associated with the NPC and are thought to be important for positioning/ 
tethering of NPCs.  
The genomics era has changed both the approaches and the scope in the 
characterization of new NE proteins.  Two genomics-based strategies have recently 
been used: homology searching and proteomics.  The Syne/Nesprin NE protein 
family was extended when a separate gene (Syne/Nesprin-2) was found in the 
human genome sequence that had considerable sequence similarity to 
Syne/Nesprin-1 [36].  Homology searching has also revealed mammalian relatives of 
proteins originally identified at the NE in worms, and vice-versa.  For example, two 
mammalian proteins, Unc84A/Sun1 and SUN2 (Sad-1 and UNC domain), were 
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found to be homologous to Unc84, a NE transmembrane protein originally identified 
in C. elegans [13].  Both mammalian proteins also target to the NE [42-44].  
Conversely, the NE transmembrane proteins emerin and MAN1 were both 
discovered in mammals, but homology searching revealed C. elegans homologs that 
function at the NE [45].  The LEM domain, originally identified by its presence in 3 
NE transmembrane proteins (LAP2-emerin-MAN1), has been observed in other 
proteins found from proteomic analysis of the NE [46] and from searching of the 
genomic databases [47].  However, LEM domains are not found exclusively in NE 
proteins: SANE is a LEM domain-containing protein that functions in the cytoplasm 
and does not appear in a nuclear fraction [48], and there are LEM domain-containing 
splice variants of LAP2 without a transmembrane sequence that are concentrated in 
the nuclear interior [49].  This emphasizes the importance of combining genomic and 
cell biological approaches to clarify protein localization and function. 
The use of proteomics to identify NE-specific transmembrane proteins is 
hampered by the fact that the ONM is continuous with the peripheral ER and is 
functionally similar to it (Figure 1).  Thus, even though the NE contains specific 
proteins for its distinctive functions, it also contains proteins present in the peripheral 
ER.  Two different proteomics strategies were used to distinguish NE-specific 
transmembrane proteins [42,46].  The first study relied on the hypothesis that 
additional NE proteins would have the same biochemical extraction characteristics 
as the known transmembrane proteins of the lamina [42].  NEs isolated from cultured 
neuroblastoma cells were extracted with chaotrope (4 M urea in 0.1 M sodium 
carbonate), generating an insoluble fraction that is enriched in integral proteins.  This 
was compared to non-ionic detergent-insoluble and salt-insoluble fractions 
containing most of the known lamina-associated INM proteins (Figure 2A).  As the 
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chaotrope fraction contains both NE and ER transmembrane proteins, it alone is 
insufficient to distinguish INM proteins.  However, proteins of the chaotrope pellet 
that were also found in the detergent/salt-extracted pellets were considered to be 
good candidates for novel INM proteins.  Each fraction was separated on 2-D gels, 
and the protein spots were excised and analyzed by MALDI mass spectrometry 
(Figure 3).  This analysis identified most, but not all, previously characterized 
transmembrane proteins of the INM, as well as mammalian Unc84A/Sun1 and a 
novel protein with no predicted functions that was named LUMA.  Both novel 
mammalian NE transmembrane proteins were shown to target to the NE by 
exogenous expression of the proteins fused to GFP [42].  An additional 19 
uncharacterized proteins were identified that did not comply fully with the 
biochemical criteria used.  However, as the known NE protein LBR also did not fully 
satisfy these criteria, some of these may prove to be novel NE proteins. 
The second study used a “subtractive” approach to exclude peripheral ER 
proteins that also were present in the NE fraction [46].  In this case a microsomal 
membrane (MM) fraction was used to identify integral ER proteins.  The MM fraction 
was analyzed separately from the NE fraction and all proteins appearing in both 
fractions were subtracted from the NE fraction (Figure 2B).  Fractions prepared from 
rodent liver were analyzed using Multi-dimensional Protein Identification Technology 
(MudPIT) [50,51], which couples tandem mass spectrometry with multiple liquid 
chromatography steps to analyze the complex mixture of peptides generated by 
direct digestion of isolated membranes without prior 2-D gel separation (Figure 3).  
This method avoids loss of many integral membrane proteins that are poorly 
resolved on 2-D gels [52].  The subtractive approach was validated by the 
identification of all expected previously characterized NE transmembrane proteins in 
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the NE fraction and their absence from the MM fraction.  In addition, 67 previously 
uncharacterized putative NE transmembrane proteins were identified in the NE 
fraction, which were absent from the MM fraction [46].  To simplify discussion, 
members of this group were called NETs (for NE Transmembrane proteins).  
However, they should be considered as  “putative” NETs until their localization has 
been confirmed by a direct assay, involving either targeting of a tagged protein to the 
NE in transfected cells or immunolocalization.  Eight of these NETs were shown to 
target to the NE when expressed in transfected cells as epitope-tagged constructs.  
This suggests that many of the remaining 59 also will prove authentic.  The large 
number of novel NE proteins identified in the second study, as compared to the first, 
is attributable to the high sensitivity of MudPIT (Figure 3) and the fact that the 
second study analyzed nuclei from liver, which is a composite of many different cell 
types rather than a cultured cell line.      
The “subtractive” and “comparative” approaches used to identify NE-specific 
proteins both had limitations.  The comparative approach disregarded NE-specific 
proteins that were not associated with the salt- and nonionic detergent-insoluble 
lamina fraction, because no other basis was provided for distinguishing between the 
NE and ER transmembrane proteins that were present in the chaotrope-resistant 
fraction.  The subtractive approach disregarded proteins that have functions in both 
the ER and the NE.  For example, a known ER protein, torsinA, appeared in both NE 
and MM fractions.  However, a fraction of torsinA appears to have specific functions 
at the NE as it is tethered there by interaction with the NE-specific transmembrane 
protein LAP1 [29].  Moreover, point mutants in torsinA resembling those responsible 
for the disease early-onset torsion dystonia preferentially accumulate in the NE [53].  
This underscores the notion that some integral proteins localized throughout the ER 
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may have binding sites and functions at the NE different from peripheral ER 
functions. 
Proteomics also has inherent limitations.  Protein identifications can be 
erroneous in the uncommon event that a peptide with a post-translational 
modification fortuitously has the same mass as a different peptide from a distinct 
protein.  Database inaccuracies also can result in failure to make protein 
identifications, since database sequences are used to predict the peptide masses 
used for comparison to the measured masses.  Finally, assignment of 
transmembrane status can be erroneous because most transmembrane prediction 
algorithms are based on the identification of long hydrophobic α-helices (> ~15-20 
residues), yet similar hydrophobic helices also can occur in the interior of folded 
proteins.  Moreover, membrane integration can also occur with multimers of beta-
barrels, (reviewed in [54]) and hydrophobic ‘domes’ inserted into the membrane 
bilayer as ‘monotopic’ proteins as postulated for FAAH [55].  
 
Numbering the set of NE proteins 
It may be some time before determination of the full set of NE proteins is possible.  
Aside from the limitations of the subcellular fractionation and proteomics strategies 
discussed above, there are potential artifacts associated with antibody localization 
and overexpression of fusion proteins, which can confound a clear determination of 
NE localization.  Most of the previously characterized NE transmembrane proteins, 
when overexpressed as transfected tagged fusion proteins, accumulate in the 
peripheral ER as well as in the NE, presumably due to saturation of binding sites at 
the NE.  Moreover, NE targeting can be obstructed by such tags: LAP1C targets 
normally if GFP is fused at its C-terminus, but not if it is fused at its N-terminus (our 
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unpublished observations).  If some proteins are tissue-specific (see below), a 
protein may target to the NE only if a relevant binding partner is present; thus ectopic 
expression in an inappropriate cell type may not yield NE localization.  The most 
rigorous determination of NE localization would involve the use of 
immunolocalization carried out with multiple affinity-purified antibodies.   
Even rigorous testing may be confounded by the existence of multiple splice 
variants that have distinct cellular locations.  Analysis of LAP2 has shown that at 
least six separate mRNAs are generated from the gene, two of which lack a 
membrane-spanning segment [56].  In addition to the NE-bound ß-variant, isotype-
specific antibodies exist only for the soluble α-variant, which localizes predominantly 
in the nucleoplasm (with minimal concentration at the nuclear rim) [49].  A wide 
variety of splice variants is also evident for the Syne/Nesprin protein families [36,38] 
and for 18 of the 67 new NETs.   
 At this point, it is unclear how many of the proteins that are localized 
throughout the ER have distinctive functions at the NE, as suggested for torsinA.  
There have been many reports of transmembrane proteins that are concentrated at 
the NE in certain tissues or conditions of cell culture, but that are not specifically 
concentrated at the NE under other circumstances.  These include proteins involved 
in lipid modification [57], second messenger signaling [58], and peptide/ ion 
transporters [59,60].  All of the above-mentioned proteins also were observed in the 
NE-enriched fraction of the “subtractive” proteomics study [46].  Since 566 total 
proteins were identified in the NE membrane-enriched fraction of that study and 148 
proteins were identified in the “comparative” study [42], it is likely that the number of 
proteins with specific functions at the NE will increase.      
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 Although the focus of this review is on transmembrane proteins, it is 
noteworthy that proteins lacking a predicted membrane-integrated region also have 
been found to concentrate at the NE, and many have been shown to bind NE 
transmembrane proteins or lamins.  Among these are several chromatin and 
chromatin-modifying proteins such as HP1, BAF (barrier-to-autointegration factor), 
histones, and the transcriptional regulator germ cell-less (GCL) (reviewed in [24]).  
Several additional soluble RNA and DNA modifying proteins were detected in both 
proteomics studies.  One of these, the mammalian homolog of Dbp5 DEAD box 
helicase, was subsequently shown to be tethered to the NPC for a role in yeast 
mRNA export [61].  Such “associated” NE proteins could be parts of larger protein 
complexes organized around NE transmembrane proteins.    
 
A different NE proteome for different tissues?  
UNCL was not identified in the “subtractive” MudPIT analysis of rodent liver NEs 
[46], consistent with other reports that it is not expressed in liver [39].  This finding 
raises the possibility that other NETs may have tissue-specific expression.  Insight 
on the expression patterns of most of the NETs identified in the subtractive 
proteomic analysis comes from data obtained with a large-scale DNA microarray-
based study of transcription (“transcriptome” analysis), which involved 61 mouse and 
72 human tissues and cell types [62].  For most NETs, considerable variation was 
observed in expression levels over the tissues sampled.  Over 4/5 of those analyzed 
exhibited greater than a 10-fold range of expression differences among the studied 
tissues, and many exhibited levels of expression no higher than background in some 
tissues [63].  Interestingly, some NETs showed preferentially high expression in a 
small number of tissues, including liver and two of the cell types present in liver, fat 
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cells and blood (Figure 4).  The strongest preferential expression in liver was 
observed for NET45, which averaged nearly 25-fold higher levels of expression in 
liver than the median value observed over all tissues.  Only a few of the NETs 
exhibited such extreme tissue-preference.  These observations support the 
hypothesis that each cell type has a small set of unique or preferentially expressed 
NE proteins.  Thus, analysis of NEs from other tissues is predicted to identify some 
additional NE transmembrane proteins that are absent from liver. 
The first indication that NE composition might be dynamic came from 
observations that lamin subtypes change in their expression during development.  
Lamins A and C, which are splice variants differing in their C-termini, usually appear 
at the time of, or following differentiation (reviewed in [1]) whereas lamins B1 and B2 
are expressed throughout development, albeit at varying levels [64].  This 
developmental regulation is likely to be important as it is observed in all vertebrates 
tested (frogs, birds, mammals) as well as in Drosophila (reviewed in [1]).  Lamin 
subtype variation also could influence the composition of membrane proteins in the 
NE, as several transmembrane proteins have been shown to target to the NE by 
lamin binding [65].  Although few transmembrane proteins have been tested for 
lamin subtype preference, LAP2ß appears to have a preference for lamin B1 [66] 
and emerin for lamin A [67,68].  Similar to lamins, the splice variants of LAP2 have 
been shown to exhibit dynamic developmental expression [69]; thus, changes in 
lamina composition during tissue differentiation may direct or facilitate a 




Surprisingly little is known about the specific functions of NE transmembrane 
proteins, even those best characterized.  Although some enzymatic activities are 
indicated by regions of homology within some of the new putative NETs, LBR is the 
only previously characterized NE transmembrane protein that appears to have 
enzymatic activity (i.e. sterol C-14 reductase).  Important clues on the functions of 
certain NE transmembrane proteins has come from analysis of their binding 
partners.  In particular, a number of proteins (e.g. emerin, MAN1, LAP2) recently 
have been found to bind signaling components and/or transcriptional regulators.  
Emerin binding proteins include lamin A, MAN1, Syne/Nesprin-1α, GCL, BAF, F-
actin, myosin I, the Btf transcriptional repressor, and the YT521-B splicing regulator 
(reviewed in [19]).  This may indicate that one of the primary functions of many NE 
transmembrane proteins is to recruit specific regulatory complexes (such as for 
chromatin modification or transcriptional regulation) to the nuclear periphery through 
unique combinations of binding partners.  In this way the NE could influence gene 
expression, and impairment of these functions could lead to disease.   
 Chromatin regulatory functions could be greatly affected by compositional 
differences in the NE between different tissues and developmental stages.  This 
encourages further study of the NE from a systems biology perspective.  It will be 
important to sample NE proteomes from a variety of different cell and tissue types in 
order to determine the extent of NE variation and to identify tissue-specific NE 
transmembrane proteins.  Once additional NETs have been identified and verified, 
determination of networks of protein interactions will help to discern tissue-specific 




We thank John Hogenesch for permission to use his transcriptome database, 
Vassiliki Lazou for assistance in ranking the transcriptome expression levels, and 
Elizabeth Fairley, Brandon Chen, and Anja Bubeck for critical reading of the 
manuscript.  We are grateful to Brandon Chen for providing Figure 1.  Larry Gerace 
is supported by NIH GM28521, and Eric Schirmer is supported by the Wellcome 
Trust. 
16 
Figure Legends and Tables 
 
Figure 1.   
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Schematic diagram of the NE.  The nuclear envelope consists of outer and inner 
nuclear membranes connected at the “pore membrane”.  The outer nuclear 
membrane (ONM) is continuous with the rough and smooth endoplasmic reticulum 
(ER).  The inner nuclear membrane (INM) contains many unique integral proteins, 
which commonly are associated with the intermediate filament lamin polymer.  The 
pore membrane (PM) apposed to the nuclear pore complexes (NPCs) contains 
specific integral proteins involved in membrane tethering of NPCs.  Depending on 
their topology and membrane subdomain, NE transmembrane proteins could have 
functions in the cytoplasm, nucleoplasm, or the perinuclear lumenal space.  ONM-
specific proteins have not been clearly identified, but may include some members of 
the Syne/Nesprin protein family.  Three general groups of transmembrane proteins 
have been demonstrated in the INM.  These include single membrane-spanners with 
most of the protein mass located in the nucleoplasm (such as LAP2 and emerin), 
double membrane-spanners that have two nucleoplasmic domains (such as MAN1), 
and multiple membrane-spanners that have several domains in both nucleoplasmic 
and lumenal compartments (such as LBR and nurim).   
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Figure 2.   
 
Proteomics subcellular fractionation strategies.  Because of NE continuity with the 
ER, identification of NE-specific proteins is confounded by ER membranes 
cofractionating with isolated NEs, and by ER-like functional properties of the ONM.  
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A.  In the comparative approach, NEs were extracted with 4 M urea in 0.1 M 
Na2CO3, generating a chaotrope-insoluble fraction that is enriched in integral 
proteins.  Membrane proteins from both the NE and ER should be well represented 
in this fraction, but all non-membrane proteins including lamins should be solubilized 
and extracted.  This fraction contained LAP2ß and calnexin, but not lamin B1 or the 
soluble NPC receptor importin ß.  NEs were separately extracted with a non-ionic 
detergent (1% Triton X-100).  This treatment should solubilize membranes and 
transmembrane proteins that are not tightly bound to a detergent-resistant structure 
(such as the lamin polymer).  Thus membrane proteins associated with the nuclear 
lamina should appear in this fraction while those of the ER should be extracted.  This 
fraction contained LAP2ß, lamin B1 and importin ß, but not calnexin.  The nuclear 
lamin polymer has unique biochemical properties that make it resistant to high salt 
concentrations; thus, transmembrane proteins associated with the nuclear lamina 
should also remain in the salt-insoluble (1 M NaCl) fraction (along with other 
membrane proteins), while soluble contaminants, such as chromatin proteins, should 
be extracted.  This fraction contained LAP2ß, lamin B1 and calnexin, but not importin 
ß.  B.  In the subtractive approach, peripheral ER proteins that also were present in 
the NE fraction were excluded by discounting proteins that appeared in a separately 
isolated microsomal membrane (MM) fraction that is rich in ER proteins.  Subtracting 
proteins that appeared in both fractions from the NE fraction yielded an “in silico” NE 
fraction.    
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Figure 3.   
 
Proteomics methodologies.  Differences in approach for the actual mass 
spectroscopy method applied between the studies likely also contributed to the 
differences in the number of protein identifications.  In the comparative proteomics 
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study (upper panel) proteins were first isolated, then digested with specific proteases 
and the peptide masses measured by MALDI-TOF.  Many peptides must be found to 
match the predicted masses of peptides generated by hypothetical cleavage for a 
particular protein in the database in order to gain statistical confidence for 
identification.  In contrast, the subtractive proteomics study (lower panel) used 
MudPIT in which the complex protein mixture is directly digested and multiple liquid 
chromatography steps are engaged to elute one peptide at a time into the mass 
analyzer.  Once the peptide mass is measured, the peptide is fragmented and the 
mass of each fragment measured.  Computer algorithms relate the possible amino 
acid compositions that could account for the full-length peptide with those of all the 
fragments and the known sequences from the protein databases.  In many cases 
this can yield a protein identification from a single peptide.       
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Figure 4.   
 
Expression diversity of NETs in different tissues.  Novel NETs were analyzed for 
expression levels in different human and mouse tissues using the Novartis 
transcriptome database accessible at “http://symatlas.gnf.org/SymAtlas/” [62].  Two 
or more experiments were available for roughly half of the 53 NETs that were 
represented on the arrays used (of the 59 putative and 8 confirmed NETs).  DNA 
microarray experiments were standardized so that expression levels could be 
compared between tissues.  The values obtained for expression in a subset of 
tissues were translated into the color-coded schematic shown.  Value ranges are 
listed in the key: a value <200 is considered to be not significantly higher than 
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background.  The NETs listed exhibited considerable tissue-preference in their 
expression profiles in liver, fat cells or blood.  NETs 37, 45, and 47 exhibited the 
highest expression levels in liver of all the tissues and cell types analyzed.  NET44 
expression levels in liver were slightly superseded in amygdala, but were still 4-fold 
higher than the median expression level.  Both adipocytes and brown fat are 
considered together as “fat cells”.  In the cases of NETs 8, 33, and 41, expression in 
liver is also high (3rd, 3rd, and 4th highest levels of expression respectively in 


























LBR yes   neutrophils 
bone 
1988 [23] 
LAP1 yes  +  1988 [26] 
gp210 ND    1990 [40] 
LAP2 yes LEM +  1993 [27] 
POM121 ND    1993 [41] 
emerin yes LEM  muscle 1996 [32] 
MAN1 yes LEM  bone 1996 [33] 
nurim yes    1999 [30] 
Syne-1 ND Spectrin 
repeats 
KASH 
+  2000 [36] 
Syne-2 ND Spectrin 
repeats 
KASH 
+  2000 [36] 
UNCL yes    2000 [39] 
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Unc84A yes SUN   2001 [42] 
LUMA yes    2001 [42] 
SUN2 yes SUN   2002 [43] 
NET3 yes    2003 [46] 
NET4 no    2003 [46] 
NET8 yes  +  2003 [46] 
NET26 no    2003 [46] 
NET31 no  +  2003 [46] 
NET39 yes    2003 [46] 
NET51 yes    2003 [46] 
NET56 yes  +  2003 [46] 
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